Home >
Medicine Info >
Myone Depot 150 mg Prefilled Syringe
Loading interface...

Myone Depot 150 mg Prefilled Syringe

Manufactured bySun Pharma Laboratories Ltd.
ContainsMedroxyprogesterone
Description
Myone Depot 150 mg Prefilled Syringe is a female hormone that is used to prevent pregnancy.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Myone Depot 150 mg Prefilled Syringe

  • Weight gain
  • Depression
  • Hot flashes
  • Joint pain
  • Breast pain and tenderness
  • Loss of vision or blurred vision
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • White vaginal discharge
  • Shortness of breath
  • Hair loss
  • Headache
  • Dizziness
  • Nausea and Vomiting

Uses of Myone Depot 150 mg Prefilled Syringe

What is it prescribed for?

  • Contraception
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before administering this medicine. Your doctor may prescribe an alternative medicine based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to medroxyprogesterone or any other inactive ingredients present along with the formulation.

Pregnancy

This medicine is not recommended for use in patients with a known or suspected pregnancy.

Breast cancer

This medicine is not recommended for use in patients with breast cancer or suspected breast cancer. Patients with a family history of breast cancer should be monitored closely during treatment with this medicine.

Liver Disease

This medicine is not recommended for use in patients with liver diseases due to the risk of adverse effects.

Undiagnosed vaginal bleeding

This medicine is not recommended for use if you have an abnormal bleeding episode which has not been diagnosed by a doctor. Report any menstrual irregularities to the doctor immediately.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before administering this medicine. Your doctor may prescribe an alternative medicine based on your clinical condition.
General warnings

Bone mineral density

The use of this medicine may induce bone loss and may increase the risk of fractures. This risk is especially higher in patients with a known history of osteoporosis. Close monitoring of the clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Other medicines

This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

Cardiovascular disorders

Use of this medicine may increase the risk of cardiovascular diseases. Hence, this medicine should be used with caution and cardiac function monitoring is required while on this medication. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Missed Dose

If an injection schedule is missed, inform your doctor immediately. Your doctor will give you further instructions about the changed dosing schedule.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Carbamazepine

Griseofulvin

Ketoconazole

Insulin

Acitretin

Protease inhibiors

Disease interactions

Breast cancer

This medicine is not recommended for use in patients with a known or suspected breast cancer due to the increased risk of worsening of the patient's condition. Patients with a strong family history of breast cancer should be monitored closely during treatment with this medicine.

Liver Disease

Use of this medicine is not recommended in patients with a history of liver diseases or active liver diseases due to the increased risk of worsening of the patient's condition.

Depression

This medicine should be used with caution in patients with a history of depression or active depression due to the increased risk of worsening of the patient's symptoms. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Thromboembolism

Use of this medicine is not recommended in patients having a clotting disorder, cerebrovascular disease, or active thrombophlebitis due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative may be necessary based on the clinical condition.

Retinal thrombosis

Use of this medicine may sometimes cause side effects such as loss of vision, blurred vision, or retinal vascular lesions. This risk is especially higher in patients with a history of vision problems or active vision problems. Any vision problems should be reported to the doctor on priority. Replacement with a suitable alternative medicine may be necessary based on the clinical condition of the patient.

Fluid retention

This medicine should be administered cautiously in patients with fluid overload or edema due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.
Food interactions
Information not available.
Lab interactions

Blood coagulation tests

Report the use of this medicine to the doctor before undergoing a test to measure the coagulation time. The use of this medicine may interfere with the test results.

Thyroid function tests

Report the use of this medicine to the doctor before undergoing thyroid function tests. This medicine may interfere with the tests and give a false-positive result.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine works by stopping the growth of the lining of the uterus and this helps in preventing pregnancy.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Contraceptives, Progestins, Hormones

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2020 [cited 7 May 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20246scs019_Depo-provera_lbl.pdf

Medroxyprogesterone Injection: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2020 [cited 28 January 2020]. Available from:

https://medlineplus.gov/druginfo/meds/a604039.html

DailyMed - Medroxyprogesterone Acetate injection, suspension [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 7 May 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ad58c4b-c263-4562-92cd-b1f81f3e06b3

Medroxyprogesterone [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 7 May 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Medroxyprogesterone

Medroxyprogesterone acetate - DrugBank [Internet]. Drugbank.ca. 2020 [cited 7 May 2020]. Available from:

https://www.drugbank.ca/drugs/DB00603
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 7 May 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.